IX Valuation

ORIX Corp

Add to Watchlist

Advanced Chart

25.440

-0.27(-1.050%)1D

Overview
Forecast
Valuation
Earnings

IX Relative Valuation

IX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, IX is overvalued; if below, it's undervalued.

Historical Valuation

ORIX Corp (IX) is now in the Fair zone, suggesting that its current forward PE ratio of 10.24 is considered Fairly compared with the five-year average of 8.60. The fair price of ORIX Corp (IX) is between 24.90 to 31.57 according to relative valuation methord.

Relative Value

Fair Zone

24.90-31.57

Current Price：25.71

Fair

10.06

Trailing

Forward

21.96

EV/EBITDA

ORIX Corp. (IX) has a current EV/EBITDA of 21.96. The 5-year average EV/EBITDA is 17.17. The thresholds are as follows: Strongly Undervalued below 8.30, Undervalued between 8.30 and 12.74, Fairly Valued between 21.61 and 12.74, Overvalued between 21.61 and 26.05, and Strongly Overvalued above 26.05. The current Forward EV/EBITDA of 21.96 falls within the Overvalued range.

23.94

EV/EBIT

ORIX Corp. (IX) has a current EV/EBIT of 23.94. The 5-year average EV/EBIT is 19.48. The thresholds are as follows: Strongly Undervalued below 15.21, Undervalued between 15.21 and 17.34, Fairly Valued between 21.61 and 17.34, Overvalued between 21.61 and 23.74, and Strongly Overvalued above 23.74. The current Forward EV/EBIT of 23.94 falls within the Strongly Overvalued range.

1.36

ORIX Corp. (IX) has a current PS of 1.36. The 5-year average PS is 1.06. The thresholds are as follows: Strongly Undervalued below 0.76, Undervalued between 0.76 and 0.91, Fairly Valued between 1.21 and 0.91, Overvalued between 1.21 and 1.36, and Strongly Overvalued above 1.36. The current Forward PS of 1.36 falls within the Overvalued range.

0.00

P/OCF

ORIX Corp. (IX) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.

0.00

P/FCF

ORIX Corp. (IX) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.

ORIX Corp (IX) has a current Price-to-Book (P/B) ratio of 1.04. Compared to its 3-year average P/B ratio of 1.16 , the current P/B ratio is approximately -10.31% higher. Relative to its 5-year average P/B ratio of 1.01, the current P/B ratio is about 3.05% higher. ORIX Corp (IX) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -1.73%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 2.92% , the current FCF yield is about -100.00% lower.

1.02

P/B

Median3y

1.16

Median5y

1.01

0.00

FCF Yield

Median3y

-1.73

Median5y

2.92

Competitors Valuation Multiple

The average P/S ratio for IX's competitors is 6.68, providing a benchmark for relative valuation. ORIX Corp Corp (IX) exhibits a P/S ratio of 1.36, which is -79.69% above the industry average. Given its robust revenue growth of -9.85%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of IX increased by 1.68% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 8.19 to 11.49.

The secondary factor is the Revenue Growth, contributed -9.85%to the performance.

Overall, the performance of IX in the past 1 year is driven by P/E Change. Which is more unsustainable.

-9.85%

5.23B → 4.72B

Revenue Growth

-28.75%

15.58 → 11.10

Margin Expansion

40.28%

8.19 → 11.49

P/E Change

1.68%